# Yohan Kim

> Yohan Kim is a Series B investor at DSC Investment backing Health Care and Therapeutics. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [DSC Investment](https://shizune.co/investors/profile/dsc-investment)
- Total investments: 4
- Last investment: Oct 2025
- Lead investor: 75%
- Last updated: Aug 2026

Yohan Kim is a Series B investor at DSC Investment focused on Health Care and Therapeutics. Yohan Kim

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Therapeutics | 2 | 50% |
| Biotechnology | 2 | 50% |
| Pharmaceutical | 2 | 50% |
| Medical | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 75% |
| Series A | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 2 | 50% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PineTree Therapeutics | PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $47M | Series B | Oct 28, 2025 |  |
| Illimis Therapeutics | Illimis Therapeutics is a platform-based biotech company that develops a chimeric fusion protein platform for neurodegenerative diseases. The company's proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform is designed to harness the therapeutic potential of TAM (Tyro3, Axl, Mer) receptor biology, a critical pathway involved inregulating inflammation and immune responses. | $41.9M | Series B | Jul 14, 2025 |  |
| MicrobiotiX | MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases. | $10.9M | Series B | Oct 21, 2024 |  |
| PineTree Therapeutics | PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $17M | Series A | Jul 30, 2024 |  |

4 of 4 investments shown.

## Co-investors
- [Schmidt](https://shizune.co/investors/profile/schmidt-4d8d) — VC Fund, 3 deals together
- [S&S Investment](https://shizune.co/investors/profile/s-s-investment-3f65) — VC Fund, 3 deals together
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 2 deals together
- [SGI Venture Capital](https://shizune.co/investors/profile/sgi-venture-capital) — VC Fund, 2 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 1 deal together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-investment) — VC Fund, 1 deal together

## About DSC Investment

VC Fund · Seoul, South Korea

DSC Investments invests in early stage and growth companies in the field of corporate identify and focus, IT, software, biotechnology, machinery, and future high-growth areas such as environment and resources.

5 contacts available at DSC Investment.

| Name | Title | Profile |
| --- | --- | --- |
| Han Tae Hoon | Managing Director | https://shizune.co/investors/profile/han-tae-hoon |
| Junam Kim | Director | https://shizune.co/investors/profile/junam-kim |
| Kyungho Lee | Managing Director | https://shizune.co/investors/profile/kyungho-lee |
| Lee Yong-hyun | Head of the DSC Investment team | https://shizune.co/investors/profile/lee-yong-hyun |
| Yohan Kim | Senior Managing Director | https://shizune.co/investors/profile/yohan-kim-b6f2 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Yohan Kim invest in?

Yohan Kim invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yohan Kim last invest?

The most recent investment recorded for Yohan Kim closed in Oct 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co